UROMEMS
UroMems is innovative per se and focuses on clearly identified clinical needs, for their prevalence, but also for their negative impact on patients’ quality of life.
UROMEMS
Industry:
Health Care Medical Medical Device
Founded:
2011-01-01
Address:
Grenoble, Rhone-Alpes, France
Country:
France
Website Url:
http://www.uromems.com
Total Employee:
11+
Status:
Active
Total Funding:
81 M EUR
Technology used in webpage:
Content Delivery Network Amazon SSL By Default HSTS Java EE OVH Express Algolia Apollo GraphQL Rocket Chat
Similar Organizations
Alignment Health
Alignment Health provides eldercare services.
Creative Biosciences
Creative Biosciences is a biomedical technology company.
Demant Technology Centre
Demant Technology Centre is an innovative R & D company.
FineHeart
FineHeart is a medical device company
FloBio
FloBio develops point-of-care diagnostics for bleeding risk based on real-time blood analysis.
HeartVista
HeartVista is a medical technology company.
OpenTeleHealth
OpenTelehealth is a universal cloud-based remote patient monitoring platform.
Osciflex
Osciflex system imitates nature’s process to prevent deadly blood clots.
Proteon Pharmaceuticals
Proteon Pharmaceuticals is an innovative biotech company.
SyMap Medical
SyMap Medical is an innovative medical device company.
Current Advisors List
Board_member
2020-05-20
Board_member
2020-05-20
Board_member
2022-05-01
Board_member
2016-01-01
Advisor
Current Employees Featured
Pierre Mozer Clinical Director and Co-Founder @ UroMems
Clinical Director and Co-Founder
Stephane Lavallee BD Director and Co-Founder @ UroMems
BD Director and Co-Founder
2011-01-01
Dr. Hamid Lamraoui co-founder and CEO @ UroMems
co-founder and CEO
Founder
Investors List
Crédit Mutuel Innovation
Crédit Mutuel Innovation investment in Series C - UroMems
Arbevel
Arbevel investment in Series C - UroMems
Hil-Invent
Hil-Invent investment in Series C - UroMems
Bpifrance
Bpifrance investment in Series C - UroMems
b2venture
b2venture investment in Series C - UroMems
European Innovation Council
European Innovation Council investment in Series C - UroMems
Wellington Partners
Wellington Partners investment in Series C - UroMems
Supernova Invest
Supernova Invest investment in Series C - UroMems
Wellington Partners
Wellington Partners investment in Series B - UroMems
Arbevel
Arbevel investment in Series B - UroMems
Official Site Inspections
http://www.uromems.com Semrush global rank: 10.32 M Semrush visits lastest month: 234
Unable to get host informations!!!
More informations about "UroMems"
UroMems - Home
UroMems ambition is to offer to the patients suffering from severe urinary incontinence a simple and efficient innovative solution. In a particularly demanding economic and regulatory context, the company’s ambition is to …See details»
UroMems - Company
UroMems was founded in 2011 and focuses on designing, developing and commercializing active implantable medical devices. The company is based at the heart of the French Alps, in the city …See details»
UroMems - Crunchbase Company Profile & Funding
Organization. UroMems . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... UroMems is …See details»
UroMems Company Profile 2024: Valuation, Funding & Investors
When was UroMems founded? UroMems was founded in 2011. Where is UroMems headquartered? UroMems is headquartered in Eybens, France. What is the size of UroMems? …See details»
UroMems - Products, Competitors, Financials, Employees, …
UroMems has successfully achieved critical milestones in research and development, clinical outcomes and building the organization, including recently securing $47 million in funding on …See details»
UroMems - Funding, Financials, Valuation & Investors - Crunchbase
UroMems is an innovative medtech company. AI Content may contain mistakes and is not legal, financial or investment advice.See details»
UroMems Company Profile - Office Locations, Competitors ... - Craft
UroMems $32.57 m in total funding,. See insights on UroMems including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
UroMems - Contacts, Employees, Board Members, Advisors
UroMems is an innovative medtech company. New. Resources. Advanced Search. Start Free Trial . Talk With Sales ... Experience the new Crunchbase, powered by AI . Experience the …See details»
UroMems
UroMems Raises Record $47 million (€44 Million) in Series C Financing to Fund Pivotal Clinical Trials of the UroActive™ System, the First Smart Automated Implant to Treat Stress Urinary …See details»
UROMEMS - European Commission
UROMEMS focuses on designing, developing, and commercialising active implantable medical devices. The company’s flagship product is UroActiv, a smart implantable Artificial Urinary …See details»
UroMems (France) Funding: €81M - medicalstartups.org
Feb 26, 2025 UroMems ambition is to offer to the patients suffering from severe urinary incontinence a simple and efficient innovative solution. UroMems is currently developing an …See details»
UroMems | Crédit Mutuel Equity
Jul 2, 2024 UroMems, a global company developing innovative, implantable mechatronics technology to treat stress urinary incontinence (SUI), today announced it has raised $47 …See details»
UroMems | Crédit Mutuel Innovation
Jul 2, 2024 UroMems, a global company developing innovative, implantable mechatronics technology to treat stress urinary incontinence (SUI), today announced it has raised $47 …See details»
UroMems Announces Results of First Patient in Smart Implant …
Jun 6, 2023 About UroMems Founded in 2011 by Professor Pierre Mozer, Hamid Lamraoui and Stéphane Lavallée, UroMems aims to restore the quality of life, dignity and self-esteem of …See details»
UroMems
About UroMems: Founded in 2011 by Pr Pierre Mozer, Hamid Lamraoui and Stéphane Lavallée, UroMems aims to restore the quality of life, dignity and self-esteem of millions of men and …See details»
UroMems’ UroActive Implant for Stress Urinary Incontinence
Feb 14, 2024 UroMems was founded in 2011 in Grenoble, France. They are developing the UroActive™ implantable device to treat Stress Urinary Incontinence (SUI), or involuntary …See details»
UroMems champions positive results for stress urinary …
Feb 15, 2024 UroMems has reported more positive results from a trial evaluating its UroActive device for the treatment of stress urinary incontinence. The France-headquartered company …See details»
UroMems completes device implants for stress urinary …
Sep 13, 2023 UroMems has completed enrolment in a clinical study investigating its automated artificial urinary sphincter to treat stress urinary incontinence (SUI). The French company …See details»
UroMems
In order to accurately control the urethral pressure, UroMems’ myoelectromechanical system is based on a reliable technology that has been approved in other medical applications. It will …See details»
UroMems
Initial clinical trial results will inform pivotal clinical study in U.S. and Europe. GRENOBLE, France & MINNEAPOLIS, Minnesota (September 12, 2023) – UroMems, a global company …See details»